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Calcium carbonate nanoparticles
stimulate cancer cell
reprogramming to suppress
tumor growth and invasion
in an organ‑on‑a‑chip system
Sandra F. Lam1, Kevin W. Bishop1, Rachel Mintz1, Lei Fang1,2 & Samuel Achilefu1,2,3,4*
The acidic microenvironment of solid tumors induces the propagation of highly invasive and
metastatic phenotypes. However, simulating these conditions in animal models present challenges
that confound the effects of pH modulators on tumor progression. To recapitulate the tumor
microenvironment and isolate the effect of pH on tumor viability, we developed a bifurcated
microfluidic device that supports two different cell environments for direct comparison. RFPexpressing breast cancer cells (MDA-MB-231) were cultured in treatment and control chambers
surrounded by fibrin, which received acid-neutralizing CaCO3 nanoparticles (nanoCaCO3) and cell
culture media, respectively. Data analysis revealed that nanoCaCO3 buffered the pH within the
normal physiological range and inhibited tumor cell proliferation compared to the untreated control
(p < 0.05). Co-incubation of cancer cells and fibroblasts, followed by nanoCaCO3 treatment showed
that the nanoparticles selectively inhibited the growth of the MDA-MB-231 cells and reduced cellular
migration of these cells with no impact on the fibroblasts. Sustainable decrease in the intracellular pH
of cancer cells treated with nanoCaCO3 indicates that the extracellular pH induced cellular metabolic
reprogramming. These results suggest that the nanoCaCO3 can restrict the aggressiveness of tumor
cells without affecting the growth and behavior of the surrounding stromal cells.
During tumor progression, cells undergo many changes to cope with the harsh environment that is created by
the rapidly expanding cells. One change that occurs is the acidification of the tumor m
 icroenvironment1–5. This
physiologic condition is driven by the upregulation of glycolysis and proton transporters that allow the cancer
cells to thrive in acidic conditions6–8. Acidic tumor microenvironment (TME) increases the invasion, metastasis,
proliferation, and drug resistance of cancer c ells1,9–14. One approach to combat these effects is to use therapies
that buffer the TME to maintain normal physiology at a pH of approximately 7.4.
Previous studies have shown that sodium bicarbonate successfully decreased tumor m
 etastasis15,16. However,
oral administration of the product ad libitum does not target the tumor directly but instead raises the global
extracellular pH, which could induce metabolic alkalosis and potential morbidity. A variety of other approaches
have been explored to modulate the acidic TME or use this phenomenon to deliver drugs via pH-responsive
NPs17,18 and cell-penetrating p
 eptides19. Among the various methods that modulate the acidic TME and enhance
drug delivery20–24, acid-neutralizing C
 aCO3 nanoparticles ( nanoCaCO3) have been particularly effective due to
their high payload and buffering capacity, facilitating drug d
 elivery17,25 and direct pH modulation of the TME26.
NanoCaCO3 have few side effects, as they degrade into calcium and CO2 and only increase the extracellular pH
to a maximum of 7.426. However, deciphering the effects of n
 anoCaCO3 on tumor cells in the complex in vivo
environment is challenging. Without a method to dynamically quantify the number of nanoparticles that accumulate in the tumor, the net effect of pH on inhibiting the acidic extracellular pH in tumors remains unclear.
This situation can cause significant variability in the results obtained and requires extensive ex vivo analysis to
identify how n
 anoCaCO3 treatment affected tumor migration.
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In this study, we determined the effect of pH changes on tumor survival and migration by simulating in vivo
flow parameters in a controlled environment using microfluidic devices. Microfluidic devices have the ability
to grow multiple cells in a 3D environment and offer precise control of fluid flow27–30. Using a transparent polymer, polydimethylsiloxane (PDMS), for device fabrication permits real-time fluorescence microscopy of the
cell growth. A bifurcate design allows half of the tissue chambers to receive n
 anoCaCO3, while the other half
receives cell culture medium. The design enabled us to directly compare the growth of tumor cells treated with
small-sized nanoCaCO3 (< 120 nm) to those without treatment on the same device. We demonstrate that not
only did n
 anoCaCO3 increase the extracellular pH asymptotically to 7.4, but they also inhibited tumor growth
and migration.

Materials and methods

Cell culture. RFP expressing MDA-MB-231 human metastatic breast cancer cells were purchased from Cell

Biolabs (San Diego, CA), and skin fibroblast cells were purchased from the Coriell Institute (Camden, New
Jersey). MDA-MB-231 cells served as an appropriate model for our study because of their sensitivity to acidic
TME31. All cells were grown in Dulbecco’s Modified Eagle Medium (DMEM, ThermoFisher, Waltham, MA)
containing 10% fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO), 1% L-glutamine (ThermoFisher), and
1% penicillin streptomycin (ThermoFisher). They were cultured in a humidified incubator at 37 °C and 5% C
 O2.

Microfluidic device design and simulations. We developed a microfluidic device that can incorporate

the experimental and control conditions on the same chip. Two tissue chambers (0.061 mm3) were located near
the upper portion of the device (experimental), and two were located near the lower portion of the device (control). Smaller chambers of plain fibrin (0.015 m
 m3) were placed adjacent to the tissue chambers to measure cellular migration. Lastly, media channels were placed on the outside of fibrin chambers. By manipulating the hydrostatic pressure difference between media channels, we were able to control fluid velocities to mimic physiological
values. To ensure proper separation between the experimental and control tissue chambers, a larger “waste”
channel was placed between the two compartments to inhibit contamination between chambers (Fig. 1A). Additionally, flow through this channel was constantly maintained via connection to a microfluidic syringe pump.
We then used AutoCAD to construct a computer-aided design of the device. Standard photolithography
methods were used to create a silicon mold of the microfluidic devices32. Briefly, SU-8 2050 (MicroChem,
Newton, MA) was spun on to a silicon wafer to a height of 100 μm. Using the printed pattern, the design was
crosslinked into the photoresist with ultraviolet exposure. After developing the pattern out of the mold, it was
silanized before pouring polydimethylsiloxane (PDMS, Dow Corning, Elizabethtown, KY) on top of it. The
PDMS mixture was prepared from a 10:1 (w/w) polymer to curing agent solution, which was mixed thoroughly.
After degassing the PDMS, it was cured overnight in a 65 °C oven. The PDMS was then peeled off, and the inlet
and outlets of the device were punched with a 16-gauge needle. To bond the PDMS device to a glass slide, both
pieces were cleaned and placed under plasma treatment for 1 min at 250 mTorr. After sealing the pieces of the
device to the glass slide, the material was placed in a 120 °C oven for at least 15 min. The device was sterilized
under ultraviolet light for at least 8 h before use.
We used COMSOL Multiphysics 5.4 (Burlington, MA) to simulate interstitial flow within the microfluidic
devices. A 2D steady-state solution of incompressible Navier–Stokes equations was solved to calculate flow
throughout the device using the Porous Media Flow module. A no slip boundary condition was used for all the
walls, and the properties of the device have been previously published27,33.

NanoCaCO3 fabrication and size characterization. NanoCaCO3 were synthesized using a gas diffu-

sion method34. Briefly, a solution of CaCl2 hexahydrate (1 g; 4.6 mmol; Sigma–Aldrich) in 200 mL of anhydrous
ethanol was added to a 400 mL beaker, which was covered with Parafilm in a desiccator containing Drierite. To
allow gas exchange, the Parafilm cover was punctured with small holes. The beaker was surrounded by 16 glass
vials (20 mL) filled with dry ammonium bicarbonate (typically 20 g per vial). Seeding and nanoparticle formation was allowed to occur over 5 days in a vacuum. The solid nanoparticles were obtained by centrifuging the
suspension in ethanol at 6800 g for 10 min in 1 mL Eppendorf tubes, air-dried over 24 h, and stored at 4 °C. The
materials were reconstituted in DMEM before use.
Transmission electron microscopy (TEM) images of the nanoCaCO3 were captured using a FEI Tecnai Spirit
Transmission Electron Microscope (FEI, Hillsboro, OR, USA) operating at an acceleration voltage of 200 kV, as
described previously34. TEM grids coated with a layer of Formvar were used throughout these studies. Dynamic
light scattering measurements of the nanoparticles in ethanol, distilled water, phosphate buffered saline (PBS),
or serum were acquired with a Malvern Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, UK) instrument
equipped with a 633 nm laser. Three measurements were conducted for each sample with at least 10 runs, each
run lasting 10 s. All sizes reported were based on the intensity average.

Microfluidic experimental design and setup. For each experiment, fibrin was used to create the extracellular matrix for the TME. Fibrinogen (Sigma-Aldrich, St. Louis, MO) and thrombin (Sigma-Aldrich) were
prepared in PBS (Gibco) for a final concentration of 16 mg mL−1 and 50 U m
 L−1 respectively. MDA-MB-231
cells were trypsinized and resuspended in the fibrinogen solution at a concentration of 3 × 106 cells mL−1. The
thrombin was then added to this mixture to initiate the polymerization process. Before the solution completely
polymerized, it was pipetted into the tissue chambers of the device. Immediately after loading the cells into the
device, plain fibrin was loaded to the adjacent chambers using the same method. The device was then placed
in a 37 °C incubator for 30 min before media was added to the media channels Tygon tubing (Saint-Gobain,
Valley Forge, PA) was connected to the inlets and outlets of the waste stream channel and attached to a syringe
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Figure 1.  Device design and setup. (A) Design of the microfluidic device. Cells in fibrin are loaded into the
brown chambers. Plain fibrin is loaded in the adjacent chambers to quantify cellular migration. Media is flown
through the pink channels to feed the tissue. The flow patterns of the device are illustrated by the arrows. The
two upper chambers will receive media with CaCO3 nanoparticles (blue arrows), while the two lower chambers
will receive plain media (red arrows). The central chamber is connected to a microfluidic pump to serve as a
“waste” stream so the upper and lower chambers can maintain independence from each other. (B) Experimental
setup of the microfluidic device. Pipette tips are used to feed the tissue chambers on the outside of the device,
while the middle media channel is connected to a microfluidic pump via tubing. (C) Fluid velocity (µm s −1)
distributions are shown in the surface map (left). The streamlines of interstitial flow are illustrated with pink
lines. Quantification of velocities along the black arrow are shown in the graph to the right. The boxed regions
in the graph represent the fluid velocities within the tissue chambers. (D) FITC-dextran flow through the top
media channel to show that the fluorescent signal is attenuated towards the lower chambers. This confirms that
there is no crosstalk between the upper and lower chambers. Scale bar = 200 µm. (E) Visual confirmation of the
presence of C
 aCO3 nanoparticles. The black punctate marks in the tissue chamber and media lines serve as a
visual representation that the CaCO3 nanoparticles are reaching the tissue chamber through the media lines.
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pump (Fig. 1B). A syringe containing media was flowed constantly for a rate of 10 nL s −1 throughout the experiments. After the device was placed in the incubator overnight, the media in the top channel was replaced with
the DMEM media containing nanoCaCO3 at selected concentrations of ≤ 0.8 mg mL−1. The media was changed
every 2 days for the 6-day experiment. For the experiment containing cancer and fibroblast cells, the cells were
loaded at a concentration of 1.71 × 106 cells mL−1 and 4.29 × 106 cells mL−1, respectively.

Imaging and tumor progression analysis. Both fluorescent and brightfield images were acquired at
the start and end of each experiment using an EVOS FL Cell Imaging System (ThermoFisher). In the experiments containing fibroblasts, a live stain was used at the end of the experiment. Briefly, Calcein AM was used to
determine cell viability and label the live cells with green fluorescence. First, the cells were washed with Hanks’
Balanced Salt Solution (HBSS, Gibco) for an hour before incubating the cells in the dye for at least 2 h. All images
were cropped to contain either the top, center, or bottom chambers. MDA-MB-231 tumor area was measured
with ImageJ by calculating the red fluorescent area. The fibroblast cells remained nonfluorescent to ensure their
properties were not altered, and their area was traced manually during image analysis to calculate the fibroblast
area on the initial day of loading. At the end of the experiment, fibroblast area was determined by subtracting
the red fluorescent area (MDA-MB-231 cell area) from the green fluorescent area (total viable cellular area). The
parameters for growth and migration were calculated using the following equations:
Growth ratio =

Migration =

Cellular area on final day
Cellular area on initial day

Total cellular area in the top or boottom chamber
Total cellular area in the central chamber

pH measurements. To estimate how n anoCaCO3 were affecting the tumor microenvironment, pH measurements were made using 24 well plates. First, MDA-MB-231 cells were seeded in the wells at a concentration of
3.0 × 106 cells mL−1. The next day, the media was replaced with either plain media (control) or media containing
0.8 mg mL-1 nanoCaCO3 (experimental). After 3 more days, the media was collected, and a pH probe (AB15
Basic, ThermoFisher) was used to measure the pH of the media in the wells.
Additionally, the intracellular pH was determined using a pHrodo Green AM Intracellular pH Indicator
(ThermoFisher) following the manufacture’s protocol. With this dye, higher fluorescent intensities indicate a
lower pH. Therefore, to correlate fluorescent intensities with pH values, a pH Calibration Buffer Kit (ThermoFisher) was used.
Statistical analysis. To test the effectiveness of n anoCaCO3 on tumor growth inhibition, a Mann–Whitney
test was used to compare the control with the experimental data sets. GraphPad Prism was used for these calculations, and the criterion for statistical significance was p < 0.05. All results are presented as mean ± standard
deviation.

Results

Microfluidic device characterization. We developed a bifurcated microfluidic device that allowed two

cell environments to be compared side by side (Fig. 1). The device was designed to control interstitial flow rates
depending on the drop in pressures along the tissue chambers. A low-pressure waste stream flowed between the
control and treatment sides. Media diffused through each chamber from high pressure to low pressure and was
cleared by the central waste stream. We incorporated 6 pores that connect the tissue chambers to fibrin chambers and media channels, which were specifically designed to be capillary burst valves to maintain the cells in
each compartment during the cellular loading process. Fluid flow direction was determined by the difference in
hydrostatic pressure head between the top and bottom channels. The flow was designed to incorporate velocities
between 1–10 µm s−1 to replicate physiological interstitial fluid flow (Fig. 1C). Fluid velocities were quantified
along the black arrow and plotted as velocity vs. distance (Fig. 1C). The velocities in the tissue chamber are
represented by the black boxes. The tissue chambers have interstitial flow rates in the physiological range of
1–10 µm/s. This event was also observed in the waste channel stream, which was pumped at a fast flow (up to
55 µm s−1) rate to prevent cross-communication between the experimental and control conditions. To further
confirm this process, fluorescein isothiocyanate-dextran (FITC-dextran) was flown through the top media channel for a day and then imaged. No fluorescent signal in the bottom chambers was observed (Fig. 1D), indicating
that the experimental and control conditions can co-exist on the same device without cross-contamination.

NanoCaCO3 synthesis and characterization. NanoCaCO3 were prepared by the method reported

previously34. The transition of the solution from clear to white and cloudy indicates the nucleation and formation of the nanoparticles. Depending on the particle size desired, this reaction can be stopped at different time
points. We obtained optimal yield and stable product by reacting 1 g CaCl2 in 200 mL ethanol with ammonium
carbonate, a carbonate source over 5 days. The size and morphology of the synthesized n
 anoCaCO3 were determined by TEM and dynamic light scattering (DLS) (Fig. 2). A representative TEM micrograph revealed that
the nanoCaCO3 were primarily spherical, with an average size of 78.6 ± 7.6 nm (Fig. 2A). The hydrodynamic
diameter (Dh) size of 120.0 nm ± 29.3 nm from DLS (Fig. 2B) was larger than the TEM mean size, probably due
to a combination of solvation effect and aggregation35. Therefore, we investigated the stability of nanoCaCO3 in
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Figure 2.  CaCO3 nanoparticle characterization. (A) Transmission electron microscope image of n
 anoCaCO3
dispersed in ethanol before drying the nanoparticles shows spherical particles with the size of 78.6 ± 7.6 nm.
Scale bar = 200 nm (main panel); 100 nm (inset). (B) NanoCaCO3 were dispersed in ethanol for dynamic light
scattering measurement, showing an average intensity-based size of 120.0 nm ± 29.3 nm. Average number of
particles-based size measurement is 101.8 ± 24.7 nm (not shown). (C–F) TEM images of nanoCaCO3 after
dispersion in distilled water (C), PBS (D), serum (E), and DMEM (F); scale bars = 100 nm for (C) and 500 nm
for (D–F).
distilled water, PBS, and serum. Unlike the TEM images for the n
 anoCaCO3 in ethanol, we found that suspensions of the nanoparticles in water or PBS formed large aggregates (Fig. 2C,D), suggesting that the less than 30%
DLS size increase in ethanol is consistent with previous reports35. In contrast, resuspension of the nanoparticles
in serum retained a high level of monodispersity (Fig. 2E). For this reason, we dispersed the nanoCaCO3 in
media (DMEM) containing 10% FBS throughout this study (Fig. 2F).

Dose–response of MDA‑MB‑231 cells to nanoCaCO3.

MDA-MB-231 cells were loaded in the central
tissue chamber and plain fibrin in the adjacent chambers (Fig. 1A). The control (bottom) and treatment (top)
chambers received only media and nanoCaCO3, respectively. Although both chambers were placed on the same
device, the flow of media through the waste stream ensures that the two conditions do not come in contact with
each other. Treatment chambers received 0.2, 0.4, 0.6, and 0.8 mg mL−1 solution of n
 anoCaCO3, and imaging
was performed over the time course of the experiment. Brightfield images of black punctate specs inside the tissue chamber provided visual evidence that the n
 anoCaCO3 entered the tissue chamber (Fig. 1E). Migration of
nanoCaCO3 embedded inside the fibrin at a concentration of 1.6 mg mL−1 provided additional visual evidence
that the particles reached the cancer cells (Fig. 3A).
A comparison of the cell proliferation rate between control and chamber treated with 0.2 mg mL−1 at day 5
did not show any statistical difference, with the control group exhibiting an average of 10.09 ± 3.37 growth ratio
(Fig. 3). In contrast, cells treated with n
 anoCaCO3 concentrations > 0.2 mg mL−1 displayed a concentrationdependent inhibition of tumor growth (Fig. 3D). The lowest tumor growth ratio of 5.40 ± 1.20 was observed
for the 0.8 mg mL−1 treatment group, which was significantly lower than the control group (p < 0.05) at day 5.
Furthermore, the quantification of the growth ratios shows that the MDA-MB-231 cells grown in the fibrin
embedded with nanoCaCO3 had significantly lower growth than the control cells (Fig. 3B). With the goal of
maximizing tumor inhibition, we used 0.8 mg mL−1 of nanoCaCO3 in all subsequent experiments.

pH quantifications. Acidic TME occurs as cancer cells proliferate. To simulate this in vivo process, we cultured MDA-MB-231 cells in 24 well plates and allowed the cells to grow for 3 days with or without nanoCaCO3.
Subsequent measurement of the media pH showed that the control group was significantly more acidic (average
pH of 7.14 ± 0.04) than cells treated with n
 anoCaCO3 (average pH of 7.25 ± 0.07), reflecting the buffering effects
of the nanoparticles (Fig. 4A). Changing the extracellular pH of cancer cells is expected to induce a response
intracellularly36. Using an intracellular pH sensor (pHrodo Green AM) that increases its fluorescence intensity
with pH increase37, we found that MDA-MB-231 cells exposed to n
 anoCaCO3 had significantly higher fluorescence intensity compared to the control group (Fig. 4B). We used a Calibration Buffer Kit to create a linear
relationship between fluorescence intensity and intracellular pH (Fig. 4C). Correlating the intensity to a specific
pH using this plot, we were able to determine the intracellular pH of 7.6 ± 0.09 and 7.05 ± 0.23 for the untreated
and treated cells, respectively (Fig. 4D).

Scientific Reports |

(2021) 11:9246 |

https://doi.org/10.1038/s41598-021-88687-6

5
Vol.:(0123456789)

www.nature.com/scientificreports/

Figure 3.  Nano CaCO3 effects on MDA-MB-231 cell growth. (A) Representative images of the MDA-MB-231
cells loaded in fibrin gels. Images of the start (top) and end (bottom) of the experiment with fibrin gels
containing 1.6 mg mL−1 concentration of CaCO3 nanoparticles is shown. Scale bar = 200 µm. (B) Embedding
CaCO3 nanoparticles inside fibrin. After embedding CaCO3 nanoparticles inside our fibrin gel, the
quantification of tumor growth showed significantly more growth under the control conditions. **** p < 0.0001.
(C) Representative images of MDA-MB-231 cells expressing RFP grown in varying concentrations of C
 aCO3
nanoparticles. Images of the tissue chambers right after loading are shown in the top row, and images at the end
of the experiment are shown in the bottom row. Scale bar = 200 µm. (D) Quantification of the effects of CaCO3
nanoparticles at varying concentrations. At 0.8 mg mL−1, tumor growth was significantly inhibited compared to
the control condition. * p < 0.05.
Scientific Reports |
Vol:.(1234567890)

(2021) 11:9246 |

https://doi.org/10.1038/s41598-021-88687-6

6

www.nature.com/scientificreports/

Figure 4.  Nano CaCO3 effects on pH. (A) After the cells were seeded in 24 well plates and received media with
or without C
 aCO3 nanoparticles, the media was collected and a pH probe was used to make measurements.
The control group (red) had significantly lower pH than the experimental group (blue). (B) A pHrodo Green
AM Intracellular pH Indicator dye was used compare the intracellular pH of the tumor cells with or without
CaCO3 nanoparticles. (C) Higher fluorescent intensity indicates lower intracellular pH, and a Calibration
Buffer Kit was used to correlate fluorescent intensity with intracellular pH. (D) The average intracellular pH
of the MDA-MB-231 cells without nanoparticles was significantly higher than those grown with nanoparticles
indicating a more alkaline intracellular pH. Scale bar = 100 µm, * p < 0.05.

NanoCaCO3 do not inhibit fibroblast growth, but do affect tumor migration. Cancer-associated

fibroblasts (CAFs) constitute the major component of breast cancer s troma38,39. Through the fibroblast-tumor
cell signaling axis, cancer cells can migrate, escape treatment and develop resistance. To simulate this in vivo
condition, we co-incubated fibroblasts with MDA-MB-231 cells in the tissue chamber and measured the growth
ratio of each cell type (Fig. 5A). Analysis of the growth pattern showed that the control group had a growth
ratio of 5.06 ± 2.85 for the MDA-MB-231 cells and 5.07 ± 2.12 for the fibroblast cells (Fig. 5B). In cells treated
with 0.8 mg mL−1 nanoCaCO3, the nanoparticles significantly inhibited the cancer growth ratio (2.10 ± 0.53) but
not the fibroblast growth ratio (5.07 ± 1.77). These results demonstrated that nanoCaCO3 can selectively inhibit
tumor growth without harming surrounding non-tumor host cells such as fibroblasts. However, given the dual
role of CAFs in the TME40, the full impact of this selective inhibition is unknown at this time.
An essential function of cancer-associated fibroblasts is to support tumor m
 igration41. Co-incubation of
fibroblasts with MDA-MB-231 cells showed that the cancer cells were more migratory than in the absence of
fibroblasts (Fig. 5C). Additionally, the MDA-MB-231 cells with fibroblasts had statistically more migration
against the flow of media (top migration chamber) than with the flow of media (bottom migration chamber).
The migration parameter was 0.78 ± 0.47 against flow and 0.07 ± 0.45 with flow. However, with the addition of
nanoCaCO3, this migration pattern was diminished and not statistically significant, as indicated with the migration parameter values of 0.80 ± 0.22 and 0.25 ± 0.23 against and with flow respectively (Fig. 5D). The moderate
increase of cancer cell migration with flow upon treatment with nanoCaCO3 suggests that these nanoparticles
could mobilize cancer cells42, making them more susceptible to chemotherapy when used as combination therapy.
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Figure 5.  CaCO3 nanoparticle effects on varying tissue types. (A) Fluorescent and brightfield microscopy
images of the control chambers (top row) and experimental chambers (bottom row) fed with C
 aCO3
nanoparticles. The left two columns include images taken right after loading of MDA-MB-231 expressing
RFP and brightfield images of both cancer and fibroblast cells. The right two columns are images of the
MDA-MB-231 cells at the end of the experiment as well as a live stain shown in GFP. Scale bar = 200 µm. (B)
Quantification of the growth of MDA-MB-231 and fibroblast cells with and without CaCO3 nanoparticles. The
data shows that there was significant inhibition of tumor growth when the nanoparticles were introduced. On
the other hand, there was no significant difference between the fibroblasts that were grown with or without
nanoparticles. *, p < 0.05; NS, not significant. (C) Quantification of cellular migration with and against the flow
of media. Without the presence of nanoparticles, the MDA-MB-231 cells migrate against flow, suggesting more
aggressive behavior. In the presence of nanoparticles, there was not a significant difference between migration
with or against flow. This suggest that C
 aCO3 nanoparticles can inhibit the invasive behavior of MDA-MB-231
cells without the nanoparticles. ****, p < 0.0001. (D) MDA-MB-231 cells in the presence of fibroblasts are more
migratory than without fibroblasts. To compare migratory vs growth of the MDA-MB-231 cells, we calculated a
parameter that divided the cell area in the top and bottom chambers (migration) by the cell area in the middle
chamber (growth). Using this parameter, we can see that the MDA-MB-231 cells growth with fibroblasts (red)
are significantly more migratory than the devices with only tumor cells (green).
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Discussion

Acidic TME is one of the hallmarks of solid t umors1. Previously considered a side product of the Warburg
effect, new evidence supports the view that cancer cells intentionally harness acidic conditions to activate tissue
degrading enzymes and alter the metabolism of stromal c ells3. Tumor acidity is associated with invasive and
metastatic behavior, which leads to higher morbidity r ates43,44. Previous studies have used this phenomenon to
activate or release drugs selectively in the acidic TME45. An interesting development is the potential use of acidneutralizing products to inhibit tumor g rowth45. Studies using sodium carbonate infusion clearly demonstrated
that the neutralizing effect can inhibit tumor growth44. Unfortunately, clinical translatability of this approach
is not realistic due to the potential induction of alkalosis. Recent studies have attempted to overcome this challenge by using nanoparticles to buffer the TME, thereby preventing an increase in a cidity46,47. Regardless of the
method, the complex in vivo environment complicates the delivery and prolonged retention of the buffering
agents in the TME.
Organ-on-a-chip technologies present a unique opportunity to culture cells in a 3D microenvironment that
is more representative of human physiology than the traditional 2D cell culture. In addition, microfluidic devices
can provide precise control over factors such as chemical gradients and fluid flow velocities. Thus, this platform
can be used to simulate critical factors of human microenvironments, such as interstitial fluid flow. Other studies
have used microfluidic devices to study MDA-MB-231 c ells48. However separate conditions are often implemented on separate devices. In this study, we developed microfluidic devices that have four separate cell culture
chambers with the ability to receive both media and agents for diverse treatment conditions. By supporting
multiple conditions on the same device, our system minimizes variability by maintaining identical temperature
or gas (O2 and C
 O2) levels throughout the device while seamlessly changing the media simultaneously to optimize test conditions. The versatility of our system allows us to incorporate extracellular matrix proteins such as
fibrin and co-incubate stromal cells such as fibroblasts with tumor cells to simulate the in vivo TME. Employing
microfluidic techniques, we have shown that persistent buffering of the TME with n
 anoCaCO3 inhibited tumor
growth and migration. By connecting a waste stream to a fluidic pump, both the treatment (upper chambers)
and control (lower chambers) conditions were implemented on the same device for direct comparison.
Quantification of the TME acidity revealed that cells treated with n
 anoCaCO3 in well plates maintained an
average pH of 7.25 ± 0.07, which is significantly higher than the control cell population that had an average pH of
7.14 ± 0.04. Although the expected pH of 7.4 was not attained, the differential buffering capacity of n
 anoCaCO3
compared to the untreated control was significant under static conditions. Given the small size of the cell population, the actual extracellular pH may be higher if measured adjacent to the secreting membrane regions. Under
dynamic conditions, we imagine the buffering capabilities of the n
 anoCaCoO3 would bring the system to a pH
closer to the expected 7.4 value.
Previous studies have shown that cancer cells undergo significant reprogramming in response to changes in
the extracellular p
 H49. To test if n
 anoCaCO3 altered cancer cell metabolism, we measured the intracellular pH
response to extracellular pH perturbation. The control group had a more alkaline intracellular pH (7.60 ± 0.09)
than the treated group (7.05 ± 0.23). This result is consistent with the findings that during tumor progression,
the intracellular pH becomes more alkaline as the extracellular pH d
 ecreases50–53. Our results suggest that
nanoCaCO3 induced cell reprogramming in response to the change in the microenvironment. The significant
increase in intracellular acidity points to a mechanism where n
 anoCaCO3 alters the efflux rate of protons in the
cells. If the observed reduction in cancer cell proliferation in the presence of nanoCaCO3 is caused by an increase
in the intracellular proton concentration, coupling nanoCaCO3 therapy with drugs that are effective under acidic
conditions will usher a new combination therapeutic strategy for cancer.
Another interesting observation from this study is the effect of fibroblasts on the behavior of MDA-MB-231
cells. Co-incubation of the tumor cells with fibroblasts increased the migratory characteristic of the cancer cells,
indicating the enhancement of a more invasive tumor phenotype. This tendency decreased in the presence of
nanoCaCO3. Furthermore, with the fibroblasts present, the tumor cells had a penchant for migrating against
the flow of media. This observation recapitulates in vivo conditions where cancer cells adopt the spindle shape
of fibroblasts to propel their metastatic tendencies against flow gradients54. Together, our results suggest that
tumor cells grown in the presence of fibroblasts exhibit more aggressive behavior than without fibroblasts.
Lastly, nanoCaCO3 inhibited the migratory effects of MDA-MB-231 cells in the presence of fibroblasts. While
the molecular mechanisms of these mechanochemical events need further studies, the pronounced effects of
nanoCaCO3 on cancer cells compared to CAFs could be attributed to the inverse role these cells play in the TME.
For example, CAFs are known to secrete proteins in the TME that reabsorb the lactate cancer cells p
 roduce55,
suggesting that nanoCaCO3 will have minimal effect on the non-lactic acid producing cells. Our work adds to
the body of evidence supporting the inclusion of drugs that can sustainably buffer the extracellular pH of solid
tumors in combinational therapies. Extension of this promising finding to other cancer cell types will determine
the broad applicability of the phenomenon in diverse cancer treatment.
With the ability to grow various cell types in the same device, we have shown that nanoCaCO3 do not affect
fibroblast growth. While the nanoparticles significantly decreased the tumor growth, there was no significant
change in fibroblast proliferation. An interplay between cancer cell killing therapies and those that can protect
stromal cells requires knowledge of combination therapies that will achieve maximum effect. Although additional
studies are warranted, our result points to a paradigm where nanoCaCO3 could sensitize cancer cells to standard
of care therapies without damaging stromal cells.
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Conclusions

The microfluidic device provides a platform to expand drug testing and examine the effects of cancer therapies
on multiple organ types. Using microfluidic devices, we can precisely control the cellular microenvironment.
This approach allowed us to recapitulate some in vivo conditions under well-controlled conditions. Our results
reveal the multidimensional therapeutic effects that n
 anoCaCO3 can exert on cancer cells. By buffering the
extracellular pH of tumors above 7.2, n
 anoCaCO3 were able to alter the trajectory of cancer cells by increasing
the intracellular acidity, inhibiting the migratory tendencies, and preventing the proliferation of more invasive
phenotypes of these cells without harming non-tumor cells. Each of these effects presents an opportunity to
leverage the vulnerability of cancer cells in the presence of nanoCaCO3 to design combination therapies and
potentiate the therapeutic effect of drugs.

Data availability

All data used in this study will be shared upon request.
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